| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
1993-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41736029d9bfcd6907b491739fc573e0 |
| publicationDate |
1993-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0559463-A1 |
| titleOfInvention |
Pharmaceutical coated cores |
| abstract |
A finely divided solid pharmaceutical dosage form for oral administration dissolved or suspended in a pharmaceutically acceptable liquid is described which pharmaceutical dosage form consists of a pharmaceutical coating on a crystalline or granular core of water-soluble or water-dispersible material. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9005652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940796-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021145817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6794411-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0059467-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2791889-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0033819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419938-B2 |
| priorityDate |
1992-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |